Treatment pattern of early-stage premenopausal breast cancer patients with low Oncotype DX score: Single center experience

被引：0
|
作者：
Al Saheli, Zaid Ihab
Ammari, Omar
Albusoul, Linda
Dabak, Vrushali S.
机构：
[1] Henry Ford Hlth Syst, Dept Hematol Oncol, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Henry Ford Hlth, Henry Ford Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12510
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
    Asad, Juhi
    Jacobson, Allyson F.
    Estabrook, Alison
    Smith, Sharon Rosenbaum
    Boolbol, Susan K.
    Feldman, Sheldon M.
    Osborne, Michael P.
    Boachie-Adjei, Kwadwo
    Twardzik, Wendy
    Tartter, Paul I.
    AMERICAN JOURNAL OF SURGERY, 2008, 196 (04): : 527 - 529
  • [2] Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer
    Yahiya Y. Syed
    Molecular Diagnosis & Therapy, 2020, 24 : 621 - 632
  • [3] Oncotype DX Breast Recurrence Score(R): A Review of its Use in Early-Stage Breast Cancer
    Syed, Yahiya Y.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (05) : 621 - 632
  • [4] Utilizing the Oncotype DX Recurrence Score in the Adjuvant Treatment Management of Node-Positive, Early-Stage Breast Cancer Patients
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 59A - 59A
  • [5] Utilizing the Oncotype DX Recurrence Score in the Adjuvant Treatment Management of Node-Positive, Early-Stage Breast Cancer Patients
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 59A - 59A
  • [6] Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer.
    Chen, C.
    Patt, D. A.
    Kazzaz, D. R.
    Shankleton, J.
    Forsyth, M. T.
    Ganesh, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity
    Moore, Jaleesa
    Wang, Fei
    Pal, Tuya
    Reid, Sonya
    Cai, Hui
    Bailey, Christina E.
    Zheng, Wei
    Lipworth, Loren
    Shu, Xiao-Ou
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (04) : 821 - 830
  • [8] Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score
    Shaw, Vikram R.
    Amos, Christopher I.
    Cheng, Chao
    CANCERS, 2023, 15 (12)
  • [9] Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
    Fayaz, Salah
    Eissa, Heba El-Sayed
    Demian, Gerges Attia
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [10] Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
    Salah Fayaz
    Heba El-Sayed Eissa
    Gerges Attia Demian
    Journal of the Egyptian National Cancer Institute, 32
12345